![]() |
市场调查报告书
商品编码
1551335
2030 年药品泡壳包装市场预测:按产品类型、材料、技术、应用、最终用户和地区进行的全球分析Pharmaceutical Blister Packaging Market Forecasts to 2030 - Global Analysis by Product Type (Carded and Clamshell), Material (Plastic Films, Aluminum, Paper & Paperboard and Biodegradable Materials), Technology, Application, End User and By Geography |
根据Stratistics MRC的数据,2024年全球药品泡壳包装市场规模为120.8亿美元,预计到2030年将达到184.4亿美元,预测期内复合年增长率为7.3%。
药品泡壳包装是保护和保存药品的主要包装方法。泡壳包装通常由预先成型的塑胶腔(泡壳)组成,其中包含单剂量的锭剂或胶囊,并用箔片等背衬材料密封。这种包装方法可确保剂量准确性,防止环境因素影响,并提供防篡改特性,这对于维护药品的完整性和安全性至关重要。
根据美国国家生物技术资讯中心(NCBI)统计,药品包装市场近年来以每年5%以上的速度成长。目前,每年市场规模估计超过200亿美元。
对方便、安全包装的需求不断增长
製药业对方便、安全包装的需求不断增长,推动了泡壳包装市场的成长。泡壳包装具有防篡改功能,可延长保质期,并可轻鬆分配单一剂量。它还透过以易于查看的方式组织药物来提高患者的依从性。随着消费者和医疗保健提供者优先考虑安全性和易用性,製药公司正在采用泡壳包装解决方案来满足这些需求,从而推动市场扩张。
原料高成本
PVC、铝箔和阻隔膜等原料容易受到价格波动和供应链中断的影响。这些成本通常会转嫁给消费者,并可能影响药品的承受能力和可用性。此外,泡壳包装製造需要专门的设备和工艺,进一步增加了整体成本。这种财务障碍可能会限制采用,特别是小型製药公司和价格敏感市场。
药品产量增加
全球药品产量的增加成为泡壳包装市场的巨大机会。随着製药商增加产量以满足不断增长的医疗保健需求,对高效、可靠的包装解决方案的需求也在增加。泡壳包装在产品保护、剂量控制和製造效率方面具有优势。这种趋势在製药业快速扩张的新兴市场尤其明显。有机会开发创新且具成本效益的泡壳包装解决方案,以满足不断增加的药品产量。
替代包装解决方案
替代包装解决方案的威胁给药品泡壳包装市场带来了挑战。瓶、棒和袋包装的创新提供了具有竞争力的选择,可能更适合某些药品或受到某些消费者的青睐。此外,永续包装趋势正在推动可取代传统泡壳包装的环保替代品的开发。
COVID-19 大流行最初扰乱了供应链,但此后提振了对药品包装的需求。人们对医疗保健和药物治疗的日益关注增加了药品的产量并增加了对泡壳包装的需求。此次疫情也加速了防篡改和注重卫生的包装解决方案的发展趋势,使泡壳包装市场受益。
预计塑胶薄膜产业在预测期内将是最大的
塑胶薄膜在药品泡壳包装市场的主导地位是由于其多功能性、成本效益和阻隔性能。塑胶薄膜,特别是 PVC 和 PET,具有优异的防潮性,并且与各种成型和密封工艺相容。由于产品清晰可见,因此也增加了消费者的信心。高阻隔薄膜的创新进一步推动了这一领域的成长,延长了产品的保质期。随着製药公司寻求高效和保护性的包装解决方案,塑胶薄膜仍然是首选,为市场扩张做出了重大贡献。
预计雷射切割产业在预测期内复合年增长率最高
药品泡壳包装市场雷射切割领域的高复合年增长率归因于其精度、效率和对复杂设计的适应性。雷射切割技术可实现复杂的形状和穿孔,提高包装功能和易用性。与传统的切割方法相比,它具有减少材料浪费、提高生产速度的优点。对客製化、患者友善包装设计的需求不断增长,正在推动雷射切割的采用。该技术能够满足严格的品质标准并支援创新的包装解决方案,正在推动市场的快速成长。
由于其强劲的製药业、严格的法规和高额的医疗保健支出,北美在药品泡壳包装市场占据主导地位。该地区对病人安全和药品完整性的关注与泡壳包装的优势是一致的。主要製药公司和包装製造商的存在也有助于该领域的持续创新。此外,北美人口老化和慢性病盛行率上升正在增加对处方药的需求,进一步推动泡壳包装市场的发展。该地区先进的包装基础设施也推动了先进包装解决方案的采用。
亚太地区药品泡壳包装市场的快速成长受到多种因素的推动。製药业的扩张,尤其是在中国和印度等国家,正在推动对先进包装解决方案的需求。医疗保健意识的提高、可支配收入的增加和人口的成长正在导致药物消费的增加。政府改善医疗保健机会的努力也促进了药品生产。此外,该地区的新兴经济体正在吸引对药品製造和包装技术的投资,推动亚太地区的成长。
According to Stratistics MRC, the Global Pharmaceutical Blister Packaging Market is accounted for $12.08 billion in 2024 and is expected to reach $18.44 billion by 2030 growing at a CAGR of 7.3% during the forecast period. Pharmaceutical blister packaging serves as a primary packaging method for safeguarding and preserving medications. It typically consists of a pre-formed plastic cavity (blister) that holds individual doses of pills or capsules, sealed with a backing material such as foil. This packaging method ensures dosage accuracy, protects against environmental factors, and provides tamper-evidence, making it essential for maintaining drug integrity and safety.
According to the National Center for Biotechnology Information (NCBI), the pharmaceutical packaging market has experienced annual growth of at least five percent per year in recent years. The market is now estimated to be worth over $20 billion a year.
Growing demand for convenient and safe packaging
The increasing demand for convenient and safe packaging in the pharmaceutical industry is driving the growth of the blister packaging market. Blister packs offer tamper-evident protection, extend shelf life, and provide easy dispensing of individual doses. They also enhance patient compliance by organizing medications in a clear, visible manner. As consumers and healthcare providers prioritize safety and ease of use, pharmaceutical companies are adopting blister packaging solutions to meet these needs, thereby fueling market expansion.
High cost of raw materials
Materials like PVC, aluminum foil, and barrier films are subject to price fluctuations and supply chain disruptions. These costs are often passed on to consumers, potentially affecting affordability and accessibility of medications. Additionally, the need for specialized equipment and processes for blister pack production further increases overall costs. This financial barrier may limit adoption, particularly among smaller pharmaceutical companies or in price-sensitive markets.
Rising pharmaceutical production
The rising pharmaceutical production worldwide presents a significant opportunity for the blister packaging market. As drug manufacturers increase output to meet growing healthcare demands, the need for efficient and reliable packaging solutions escalates. Blister packaging offers advantages in terms of product protection, dosage control, and manufacturing efficiency. This trend is particularly pronounced in emerging markets where pharmaceutical industries are rapidly expanding. The opportunity lies in developing innovative, cost-effective blister packaging solutions that can keep pace with the growing pharmaceutical production volumes.
Alternative packaging solutions
The threat of alternative packaging solutions poses a challenge to the pharmaceutical blister packaging market. Innovations in bottle packaging, stick packs, and pouches offer competing options that may be more suitable for certain medications or preferred by some consumers. Additionally, sustainable packaging trends are driving the development of eco-friendly alternatives that could potentially replace traditional blister packs.
The COVID-19 pandemic initially disrupted supply chains but subsequently boosted demand for pharmaceutical packaging. Increased focus on healthcare and medication led to higher production of drugs, driving demand for blister packaging. The pandemic also accelerated trends towards tamper-evident and hygiene-focused packaging solutions, benefiting the blister packaging market.
The plastic films segment is expected to be the largest during the forecast period
The plastic films segment's dominance in the pharmaceutical blister packaging market is driven by its versatility, cost-effectiveness, and barrier properties. Plastic films, particularly PVC and PET, offer excellent moisture protection and are compatible with various forming and sealing processes. They allow for clear visibility of the product, enhancing consumer confidence. The segment's growth is further fueled by innovations in high-barrier films that extend product shelf life. As pharmaceutical companies seek efficient, protective packaging solutions, plastic films continue to be the preferred choice, contributing significantly to market expansion.
The laser cutting segment is expected to have the highest CAGR during the forecast period
The laser cutting segment's high CAGR in the pharmaceutical blister packaging market is attributed to its precision, efficiency, and adaptability to complex designs. Laser cutting technology allows for intricate shapes and perforations, enhancing package functionality and ease of use. It offers advantages in terms of reduced material waste and increased production speeds compared to traditional cutting methods. The growing demand for customized, patient-friendly packaging designs is driving the adoption of laser cutting. This technology's ability to meet stringent quality standards and support innovative packaging solutions is fueling its rapid growth in the market.
North America's dominance in the pharmaceutical blister packaging market is driven by its robust pharmaceutical industry, stringent regulations, and high healthcare expenditures. The region's focus on patient safety and drug integrity aligns well with the benefits of blister packaging. The presence of major pharmaceutical companies and packaging manufacturers contributes to continuous innovation in this sector. Additionally, the growing aging population and increasing prevalence of chronic diseases in North America are boosting demand for prescription medications, further driving the blister packaging market. The region's advanced healthcare infrastructure also supports the adoption of sophisticated packaging solutions.
The Asia Pacific region's rapid growth in the pharmaceutical blister packaging market is fueled by several factors. The expanding pharmaceutical industry, particularly in countries like China and India, is driving demand for advanced packaging solutions. Rising healthcare awareness, increasing disposable incomes, and growing populations are contributing to higher medication consumption. Government initiatives to improve healthcare access are also boosting pharmaceutical production. Additionally, the region's emerging economies are attracting investments in pharmaceutical manufacturing and packaging technologies, propelling growth in the Asia Pacific region.
Key players in the market
Some of the key players in Pharmaceutical Blister Packaging market include Amcor plc, WestRock Company, and Constantia Flexibles, alongside other significant contributors like Klockner Pentaplast Group, Honeywell International Inc., Bemis Company Inc., ACG Pharmapack Pvt. Ltd., Sonoco Products Company, Bilcare Research Inc., Winpak Ltd., Uflex Ltd., RENOLIT SE, Tekni-Plex, Inc., Carcano Antonio S.p.A., Caprihans India Limited, The Dow Chemical Company, DuPont de Nemours, Inc., and PCI Pharma Services.
In July 2022, Honeywell's Aclar range of barrier film blisters received technical recyclability recognition from TerraCycle, marking a milestone in pharmaceutical packaging recyclability.
In April 2021, Amcor announced customer trials for AmSky, the world's first recyclable polyethylene-based thermoform blister packaging. It's designed to meet stringent pharmaceutical packaging requirements while being recyclable.
In February 2020, Sonoco's Alloyd division introduced EnviroSense PaperBlister, an all-paper retail blister package as an environmentally friendly alternative to thermoformed plastic blister packages.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.